Stocks
Haemonetics Corporation (HAE) EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 178.5 | 249.3 | 249.3 | 262.1 | 265.7 | |||
| Changes by years, y/y, % | +25% | +40% | 0% | -100% | +6.3% | ||||
Haemonetics Corporation. EBITDA US GAAP, bln rub
Haemonetics Corporation. EBITDA US GAAP, changes, %
Haemonetics Corporation. EBITDA US GAAP, sum by quarters, bln rub
Haemonetics Corporation (HAE) EBITDA US GAAP (quarter values) |
||||||||
| 2024Q3 | 2024Q4 | 2024Q4 | 2025Q1 | 2025Q2 | LTM ? | |||
| EBITDA, bln rub | ? | 69.5 | 61.7 | 78.8 | 73.5 | 51.7 | 265.7 | |
| Changes by years, y/y, % | +4% | +4% | +33% | -4% | +46% | |||
| Changes by quarters, q/q, % | +97% | -11% | +28% | -7% | -30% | |||
